Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006-05)
Author(s):
Velde, C.J.H. van de (0000-0003-0104-1800); Blok, E.; Kranenbarg, E.M.K.; Putter, H.; Bosch, J. van den; Maartense, E.; Carpentier, M.D.; Leeuwen-Stok, E. van; Liefers, G.J.; Nortier, J.; Rutgers, E.; Kroep, J.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-02-28
Language
English
Is part of
European Journal of Cancer (2017), Vol. 72, p. S9-S9
